top of page

Helping more women with breast cancer preserve their affected breast for improved survival

Dr Mona Tan

Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot

Dr Tan's Profile 

Dr Tan has more than 30 years of experience as a medical professional.  She dedicated most of her surgical career to treating women with breast cancer.  She has conducted an audit of the patients she has personally treated.  Her analysis revealed that 85% of her patients undergo breast conservation surgery, and the 5-year survival rate of these patients are comparable to, and in some instances, higher than those reported by several local and other Asian institutions.  During her sabbatical, she continued to be active in the academic field, publishing articles on breast surgery in international journals and serving as an academic reviewer.  She also worked towards an additional degree in addition to the ones she already has, and is proud to announce that she has been admitted as a Fellow of the American College of Surgeons.

 

She decided to return to active clinical practice to apply her expertise to assist women who specifically wish to undergo breast conservation treatment.  

Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot

Dr Tan, who is always conscious about offering patients what she believes is the best form of treatment for their specific condition, studies the outcomes for her patients and presents her findings at international breast cancer conferences.

Title

Contact

Dr Tan's international co-authors & collaborators

Professor Edibaldo Silva is Professor Emeritus of Surgery at University of Nebraska Medical Centre

Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot

Associate Professor Tibor Tot is a pathologist at University of Uppsala, Sweden

Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot

Professor Owen Ung is Head of Academy of Surgery, University of Queensland

Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot
Dr Mona Tan is a Breast Cancer Surgeon in Singapore who advocates breast conservation treatment or lumpectomy instead or tot

Or call +65 6694 1704

Dr Mona Tan's Publications

  1. Tan MP, Sitoh YY.  The unifying concepts of the sick lobe hypothesis and field cancerization and breast conservation treatment for multiple ipsilateral breast cancers: a narrative review.  Gland Surg 2023;12:535-547

  2. Silva E, Meschter S, Tan MP.  Breast biopsy techniques in a global setting – clinical practice review.  Translational breast cancer research 2023;4:14.

  3. Tan MP.  Implications of the evidence for breast conservation therapy in BRCA-gene mutation carriers.  Br J Radiol 2020;93(1108):20200038 doi10.1258/bjr.2020038

  4. Tan MP.  Circumspect use of oncoplastic surgery.  Breast 2020;49:201. Doi10.1016/j.breast.2018.12.003

  5. Silva E, Tan M.  ASO Author Reflections: Why the Surgeon, Who is the Person Most Influential in the Management of Breast Cancer, Must Have a Multidisciplinary Mindset.  Ann Surg Oncol 2019.  Doi:10.1245/s10434-019-08053-9.

  6. Tan M, Silva E.  If not now, when?  The case for a target rate of re-excision for breast-conserving surgery as a standard of care quality measure.  Breast J 2019;25:1306-1307.

  7. Silva E, Tan M.  The impact of margin status on Breast Conservation Rates.  Ann Surg Oncol 2019;25:3931-3938.

  8. Tan MP, Sitoh NY, Sitoh YY.  Does the classification system for multifocal and multicentric breast cancers alter breast conservation rates?   Breast J. 2019;25:772-774.

  9. Tan MPC, Sitoh YY.  Are breast conservation treatment rates optimized for Asian women with symptomatic malignancies?  ANZ J Surg 2019;89:529-535.

  10. Tan MP, Tot T.  The sick lobe hypothesis, field cancerization and the new era of precision breast surgery.  Gland Surg 2018;6:611-618.

  11. Tan MP, Silva E.  Future perspectives for breast conservation treatment: science & art.  Gland Surg 2018;7:501-505.

  12. Tan MP.  Is oncoplastic breast surgery truly associated with a lower rate of surgical site complications compared to standard breast conserving surgery? Am J Surg 2018;218:440.

  13. Tan MP, Silva E.  Addressing the paradox of increasing mastectomy rates in an era of de-escalation of therapy: Communication strategies.  Breast 2018;38:136-143.

  14. Tan MP.  Tan MP.  Refining Tumor Resection Techniques for Managing Inferior Pole Breast Malignancies.  Ann Surg Oncol 2017;24 (Suppl 3):590-591

  15. Tan M, Wong E, Amy D, Tot T.  Integrating anatomy, radiology, pathology and surgery: an alterantive approach in resecting multifocal and multicentric breast carcinoma.  Breast J 2017;23:663-669 doi: 10.1111/tbj.12891.

  16. Tan MP.  Minimalist breast conserving surgical approaches for inferiorly sited cancers.  Gland Surgery 2017;6:399-409.

  17. Tan MP.  Integration of ‘sick lobe hypothesis’ with concept of field cancerization for a personalised surgical margin for breast conserving surgery.  J Surg Oncol 2017;116:954-955. Doi.1002/jso.24728

  18. Tan MP.  Reduction mammoplasty: Potential for overtreatment?  J Surg Oncol 2017;116:559-560. Doi:10.1002/jso.24716.

  19. Tan MP.  Oncoplastic to Onco-Aesthetic Surgery: a movement toward overtreatment?  Arch Plast Surg 2017;44:85-86

  20. Tan MP, Sitoh NY, Sitoh YY.  Optimising Breast Conservation Treatment for Multifocal and Multicentric Breast Cancer: A Worthwhile Endeavour?: Reply.  World J Surg 2017;41:346-347.

  21. Tan MP.  Mastectomy versus breast conservation treatment: is there a true survival difference?  Breast Cancer Res Treat 2016;158:601-3

  22. Tan MP, Sitoh NY, Sitoh YY.  Optimising breast conservation treatment for multifocal and multicentric breast cancer: a worthwhile endeavour?: Reply.  World J Surg 2017 41:346-347.

  23. Tan MP.  Is there an Ideal Breast Conservation Rate for the treatment of breast cancer?  Ann Surg Oncol 2016;23:2825-31.

  24. Tan MP.  Toward a reductionist approach to the surgical treatment of breast cancer. J Am Coll Surg 2016;222:967

  25. Tan MP.  The arrowhead approach for malignancies in the lower hemisphere of the breast. Gland Surg 2016;5:83-85

  26. Tan MP, Sitoh NY, Sitoh YY.  Optimising breast conservation treatment for multifocal and multicentric breast cancer: a worthwhile endeavour?  World J Surg 2016;40:315-22.

  27. Tan MP, Sitoh NY, Sitoh YY.  Perspectives of cosmesis following breast conservation for multifocal and multicentric breast cancers.  Int J Breast Cancer 2015. doi: 10.1155/2015/126793.

  28. Tan MP.  A novel segment classification for multifocal and multicentric breast cancer to facilitate breast-conservation treatment.  Breast J 2015;21:410-7. Doi: 10.1111/tbj.12424

  29. Tan MP, Sitoh NY, Sitoh YY.  Minimising unnecessary mastectomies in a predominantly Chinese community.  Int J Surg Oncol 2015;2015:684021. Doi:10.1155/2015/684021.

  30. Tan MP, Sitoh NY, Sim AS.  Breast conservation treatment for multifocal and multicentric breast cancers in women with small-volume breast tissue.  ANZ J Surg 2014 Dec 5. Doi:10.1111/ans.12942

  31. The value of intraoperative frozen section analysis for margin status in breast conservation surgery in a non-tertiary institution.  Int J Breast Cancer 2014, Article ID 715404

  32. Tan MP, Sitoh NY, Sim AS.  Evaluation of eligibility and utilization of breast conservation treatment in an Asian context.  Asian Pac J Can Prev 2014;15:4683-4688.

  33. Tan MP, Sitoh NY, Sim AS.  Breast conservation surgery for multiple synchronous malignancies in an Asian community.  ANZ J Surg 2014;84(S1):16

  34. Tan MP. Re: Twenty-five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: a randomized screening trial.  BMJ 2014;348:g366

  35. Tan MP.  Simplifying level 2 oncoplastic surgery for lower inner quadrant breast cancers. Ann Surg Oncol 2017;24(Suppl 3):594-595

  36. Tan MP.  How I Do It: The Anchor Incision for Low Central Breast Tumours.  ANZ Journal of Surgery 2012;82:375-6.

  37. Tan MP.  Alternatives for Optimizing Oncoplastic Breast Surgery.  Ann Surg Oncol. 2012 Jul;197:2327-33

  38. Tan M, Ung O.  Alternative approaches for oncoplastic breast surgery.    Ann Surg Oncol 2011;18(1):297-9.

  39. Tan MP.  The ‘golf-tee’ incision for lower mid-pole peri-areolar cancers.  Ann R Coll Surg Engl 2010;92(5):438-9.

  40. Tan MP.  Parenchymal rearrangement may be used routinely in smaller volume breast tissue for optimal cosmesis.Plast Reconstr Surg 2009;124(3):1002-4.

  41. Tan MP.  Areola-sparing techniques for breast malignancies with nipple discharge.  J Am Coll Surg 2009;208:e1-6

  42. Tan MP.  An algorithm for the integration of breast magnetic resonance imaging into clinical practice.  Am J Surg 2009;197:691-3

  43. Tan MP.  Breast lymphatic anatomy and implications for sentinel lymph node biopsy.Ann Surg Oncol 2008;15:2345-6.

  44. Tan MP.  Cost/Accuracy ration analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy and frozen section of note.  World J Surg 2009;32:125-6.

  45. Tan MP.  The Boomerang Incision for Periareolar Breast Malignancies.  Am J Surg 2007;194:690-3.

  46. Tan MP, Ung O.  Surgical approach to the angular vein of the axilla: an ‘inverted’ technique to axillary dissection.  The Breast Journal 2007;13(2):220-222.

  47. Tan MP.  Langer’s axillary arch: Anatomy, embryological features and surgical implications.  Surgeon 2006;4(4):252.

  48. Tan MP.  Surmounting the challenges of sentinel lymph node biopsy for breast cancer in non-tertiary centres and community-based practices.  ANZ Journal of Surgery 2006; 76: 306-9.

  49. Ung O, Tan M, Chua B, Barraclough B.  Complete axillary dissection: A technique that still has relevance in contemporary management of breast cancer.  ANZ Journal of Surgery 2006; 76:518-21.

  50. Tan MP.  Additional considerations in the application of oncoplastic approaches.  Lancet Oncology 2005;5:355-6.

  51. Tan YY, Wee SB, Tan MP, Chong BK.  Positive predictive value of BIRADS categorization in an Asian population.  Asian Journal of Surgery 2004;27(3):186091

  52. Chan CY, Tan M.  Spatial Relations of the angular vein, an important landmark in axillary nodal dissection.  British Journal of Surgery 2003; 90:948-949.

  53. Tan MP, Agarwal G, Delbridge L.  Impact of timing on completion thyroidectomy for thyroid cancer.  British Journal of Surgery 2002;89:802-804.

  54. Tan MP, Sandelin K, Ung O, Lam T.  Immediate Breast Reconstruction in a State Cancer Institute - The Challenges Ahead.  ANZ Journal of Surgery May 2001; 71(Suppl):A16

  55. YY Tan, SB Wee, M Tan, Chong BK.  Needle guided open surgical biopsy of non palpable breast lesions – A six year review.  The Breast Journal 2001; 7(suppl 5):40

  56. Tan MP, Cheong DM.  Life-threatening Perineal Gangrene from Rectal Perforation Following Colonic Hydrotherapy: A Case Report.  Annals of Academy of Medicine of Singapore 1999; 28(4):583-5

  57. Sitoh YY, M Tan, et al.  Spiral Computed Tomography Demonstration of Active Haemorrhage in Abdominal Trauma.  S’pore Med Journal 1998 Jan; 39(1):32-3

  58. Tan MP, AFPK Leong.  Dieulafoy's Lesion of the Rectum.  Techniques in Proctology 1997; 1:146-147

  59. Wang Y, Qiao L, Yang K, et al.  Serum semaphoring 4C as a diagnostic biomarker in breast cancer: A multicentre retrospective study.  Cancer Commun (Lond). 2021;41:1373-1386

  60. Gong C, Cheng Z, Yang Y, et al.  A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.  Sci China Life Sci 2022. Doi: 10/1007/s11427-022-2104-3.

bottom of page